EVOMMUNE INC
HQ - Palo Alto
Summary
Evommune is a clinical-stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 89 M
Avg. Deal Size£ 89 M
All rights reserved. Copyright © 2025 Datasite
